1. miR-135a Confers Resistance to Gefitinib in Non-Small Cell Lung Cancer Cells by Upregulation of RAC1
   Tingting Zhang et al, 2018, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
2. Symmetrical drug-related intertriginous and flexural exanthema secondary to epidermal growth factor receptor inhibitor gefitinib
   Beatrice Copps et al, 2020, JAAD Case Reports CrossRef
3. Local cortisol activation is involved in EGF-induced immunosuppression
   Sayaka Matsumura et al, 2017, Dermato-Endocrinology CrossRef